InventisBio Announces $147 Million Series D Financing Led by Hillhouse Affiliate GL Ventures

InventisBio, a clinical stage biotech company dedicated to the research and development of innovative small molecule drugs, announced the recent completion of a $147 million series D financing which …
( read original story …)

---